Sequence Effect on Endogenous Drugs [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-02-10 21:09 (4521 d 16:33 ago) – Posting: # 12390
Views: 10,728

Hi Lucas,

❝ We conducted a crossover 2x2 study of Levothyroxine 65ug and found a significant sequence effect (considering a significance level of 10%). According to ANVISA guidelines, a siginifcant sequence effect can only be desconsiderd if (...)


This isn't sounding good. Before writing it off, I'd look at the data production. Did you observe a period effect (thyroid seasonal variation with 70day washout)? Did you check if your randomisation was useful?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
286 visitors (1 registered, 285 guests [including 19 identified bots]).
Forum time: 14:42 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5